magneTic brAin stimUlation foR people with mUltiple Sclerosis (TAURUS trial)

The TAURUS.2 trial is looking for people with multiple sclerosis (MS)

This participant-based study is now recruiting!

Can you help our researchers find out if low intensity magnetic brain stimulation (MBS) is an effective treatment for MS?  We are looking for 108 people with MS for the TAURUS.2 trial which has now commenced at six sites across Australia. We will measure the effects of magnetic brain stimulation (MBS for short) on multiple sclerosis (MS). MBS can non-invasively and painlessly activate nerve cells in the human brain and can be used to change nerve cell activity. MBS is currently used to treat depression but has only been used for MS in the research setting.

Participant inclusion criteria:

  • Aged 18-65
  • Diagnosed with MS by an MS neurologist (McDonald criteria 2018)
  • Stable and relapse-free for 6 months (either on or off MS treatment)
  • Extended Disability Status Scale (EDSS) between 1.5 and 6 (inclusive)
  • Willing to travel to the site every weekday for 4 consecutive weeks
  • Capacity to provide informed consent
  • Access to the internet

For full details about what's involved, the study aims and exclusion criteria go to mstrials.org.au/taurus2

For more information, please contact the study coordinator at the study site nearest you:

Hobart (Menzies Institute for Medical Research)

Kate Probert Clinical Trials Study Coordinator, Multiple Sclerosis (MS)
Email: katherine.probert@utas.edu.au
Ph: (03) 6226 7746

Dr Vincent Chigozie Ezegbe, Clinical Research Fellow, Multiple Sclerosis (MS) Research Flagship
Email: vincent.ezegbe@utas.edu.au
Ph: (03) 6226 4236

Mr Amin Zarghami, Graduate Research Student
Email: Amin.Zarghami@utas.edu.au
Ph: (03) 6226 4656

Launceston
Monika O’Connor
The Launceston General Hospital
274-280 Charles St, Launceston TAS 7250

Email: monika.oconnor@ths.tas.gov.au

Melbourne
Gerard Loquet
Alfred Health
55 Commercial Rd, Melbourne VIC 3004

Email: G.Loquet@alfred.org.au

May Ho
Alfred Health
55 Commercial Rd, Melbourne VIC 3004
Email: ma.ho@alfred.org.au

Newcastle
Kira Groen
John Hunter Hospital, Hunter New England Health
Lookout Rd, New Lambton Heights NSW 2305

Email: kira.groen@health.nsw.gov.au

Perth
Petrina Keating
Perron Institute for Neurological and Translational Science
RR Block, QE II Medical Centre,
8 Verdun St, Nedlands, WA 6009

Email: petrina.keating@perron.uwa.edu.au

Brisbane
Tamara Powell
The Mater Research
Level 3, Aubigny Place, Raymond Terrace
South Brisbane, Qld 4101
Email: tamara.powell@mater.uq.edu.au

This study has been approved by the University of Tasmania Human Research Ethics Committee (ref: H0026359) and the Hunter New England, Human Research Ethics Committee (ref: 2022_ETH01144) (national mutual acceptance).

Related Diseases

Staff

Team Leaders (Hobart)

Team Members (Hobart)

  • Prof Bruce Taylor
  • Dr Kaylene Young
  • Dr Mark Hinder
  • A/Prof Jennifer Rodger
  • Prof Michael Barnett
  • Dr Carlie Cullen
  • Mr Amin Zarghami
  • Dr Vincent Chigozie Ezegbe
  • Ms Tram Nguyen
  • Dr Kalina Makowiecki
  • Ms Kate Probert
  • Ms Angela McKecknie
  • Ms Natasha Stevens
  • Ms Vivienne Jones
  • Ms Julie Sansom
Back to top